Contract A207_PO-0451901

The University of Virginia awarded contract A207_PO-0451901 to StemCell Technologies Inc on June 25, 2026, for the procurement of specialized biological reagents totaling $2,089.57. The contract encompasses two primary product categories: DNAse I Solution at a concentration of 1 milligram per milliliter (one unit of 10 x 1 milliliter vials) and Collagenase/Hyaluronidase solution in 10-milliliter quantities (five units). The line items reflect unit prices of $637.32 for the DNAse I Solution and $290.45 each for the Collagenase/Hyaluronidase, with delivery directed to Marcus Jerryd Meade.

These enzymatic reagents are commonly utilized in laboratory and research applications involving tissue dissociation and cell isolation procedures. As a prime contractor award issued by an academic research institution in Virginia, the contract represents a routine procurement of consumable materials supporting the University of Virginia's research operations. The modest contract value and nature of the deliverables indicate this is a single-order transaction rather than an ongoing service agreement, with all materials designated for delivery to the specified recipient within the University of Virginia's research facilities.